Chemical formula: C₁₄H₂₁N₃O₂S Molecular mass: 295.4 g/mol PubChem compound: 5358
Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02CC01 | Sumatriptan | N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| IMITREX Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| IMIGRAN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| IMIGRAN Nasal spray, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| IMIGRAN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| IMITREX Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| IMITREX Nasal spray | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Sumatriptan is an active ingredient of these brands:
United States (US)
Austria (AT)
Brazil (BR)Cyprus (CY)
Ecuador (EC)
Germany (DE)
Hong Kong (HK)
Israel (IL)
Italy (IT)
Japan (JP)
Malta (MT)
Mexico (MX)
Netherlands (NL)
New Zealand (NZ)Poland (PL)Romania (RO)South Africa (ZA)
Spain (ES)
Tunisia (TN)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
